scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.EJPHAR.2013.06.006 |
P698 | PubMed publication ID | 23791611 |
P2093 | author name string | Jin Yang | |
Xiao-dan Wang | |||
Jie-ming Qu | |||
Kai-xiong Liu | |||
P433 | issue | 1-3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 120-124 | |
P577 | publication date | 2013-06-18 | |
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | The changes induced by cyclophosphamide in intestinal barrier and microflora in mice | |
P478 | volume | 714 |
Q55400532 | A Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides. |
Q48005842 | C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1, occludin and claudin-4 expression |
Q62802243 | Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment |
Q97067045 | Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model |
Q28076294 | Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment |
Q56036313 | Dietary fucoidan of Acaudina molpadioides and its enzymatically degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice |
Q41490537 | Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury |
Q35226638 | Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy. |
Q47722011 | Effects of polysaccharides from purple sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide treated mice. |
Q90248075 | Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment |
Q89429091 | Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities |
Q36088090 | Immunosuppression, peripheral inflammation and invasive infection from endogenous gut microbiota activate retinal microglia in mouse models. |
Q64118992 | KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice |
Q35932477 | Lactobacillus plantarum NCU116 attenuates cyclophosphamide-induced intestinal mucosal injury, metabolism and intestinal microbiota disorders in mice. |
Q65001698 | Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. |
Q92258393 | Myricetin Abrogates Cisplatin-Induced Oxidative Stress, Inflammatory Response, and Goblet Cell Disintegration in Colon of Wistar Rats |
Q55040688 | Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. |
Q57099887 | The Polysaccharides from Modulates the Immunity and Intestinal Microbiota of Cyclophosphamide-Treated Immunosuppressed Mice |
Q91272530 | The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model |
Q49276632 | The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells |
Q31144277 | The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide |
Q37707075 | The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice |
Q35346303 | The role of the microbiota in inflammation, carcinogenesis, and cancer therapy |
Q41545568 | The squid ink polysaccharides protect tight junctions and adherens junctions from chemotherapeutic injury in the small intestinal epithelium of mice |
Search more.